tickrz reports
tickrz rank
A
Davita Inc (DVA)
Healthcare | Health Services
57.54  -5.89%
FACTOR RANKINGSFACTOR SCREENER 
tickrz RankA / 72Warren Buffett RankA / 27
Pure Value RankA / 20Dividend RankD / NO DIVIDEND
Moat RankC / 291Financial Strength RankC / 242
Growth RankA / 45Momentum RankD / 421
DVA vs HEALTH SERVICES SECTOR & S&P 500
VALUATION
DVASECTORS&P 500
P/E RATIO8.8732.119.28
EV/EBITDA RATIO6.261711.77
P/S RATIO0.753.62.03
P/B RATIO2.285.53.09
QUALITY
RETURN ON EQUITY24.02%15.64%13.82%
RETURN ON CAPITAL13.01%50.61%10.04%
NET MARGIN5.97%8.18%9.76%
DIVIDEND ANALYSIS
DIVIDEND YIELD
0%
PAYOUT RATIO15.8%
3 YR DIVIDEND GROWTHN/A
FINANCIAL STRENGTH
PIOTROSKI F SCORE
7 OUT OF 9
DEBT-TO-EQUITY145%
INTEREST COVERAGE4.11x
CURRENT RATIO1.45
GROWTH
5 YR EPS GROWTH11.39%
5 YR SPS GROWTH16.13%
5 YR BPS GROWTH15.88%
About tickrz
Key Concepts
Great Investors
tickrz A-Ranked Davita Inc scores well on valuation
tickrz rank A / 72
Davita Inc receives an A ranking in our proprietary multi-factor ranking approach that blends valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.
value
pure value ranking A / 20Warren Buffett ranking A / 27
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Davita Inc's valuation score is comprised of a P/E ratio of 8.9x, a P/B ratio of 2.3x, a P/S ratio of 0.8x, and an EV/EBITDA ratio of 6.3x. Davita Inc ranks 20 out of the S&P 500 constituents on valuation--a relatively strong score.Davita Inc ranks 27 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Davita Inc warrants further investigation.

quality
moat C / 291financial strength C / 242
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is weak. Its position within the Healthcare sector appears to be weak. Either the dynamics of its sector place it in a difficult position or management's executition is to blame for its disappointing performance.Davita Inc has a Piotroski F Score of 7 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 4.11x, a debt/equity ratio of 145% and a Moat Rank of 291 translate to a weak Financial Strength score.


momentum D / 421
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors.The company has seen its stock fall by -11.07% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 421. Based on its 12 month stock performance, Davita Inc will not appeal to momentum investors.

yield D / NO DIVIDEND
value + yield
Davita Inc currently does not pay a dividend so it ranks last among S&P 500 companies using our dividend ranking methodology. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

growth A / 45
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 11.4% 5 year annualized EPS growth, 16.1% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 15.9% speak to its impressive growth ranking.

Davita Inc (DVA)
Healthcare | Health Services
57.54  -5.89%


tickrz rank
A
VALUATION RATIOS
P/E Ratio8.87x
P/B Ratio2.28x
P/S Ratio0.75x
EV/EBITDA Ratio6.26x
DIVIDEND ANALYSIS
DIVIDEND YIELD
0%
PAYOUT RATIO15.8%
3 YR DIVIDEND GROWTHN/A
FINANCIAL STRENGTH
PIOTROSKI F SCORE
7 OUT OF 9
DEBT-TO-EQUITY145%
INTEREST COVERAGE4.11x
CURRENT RATIO1.45
MOAT
ROE24.02%
ROIC13.01%
Net Margin5.97%
GROWTH
5 YR EPS GROWTH11.39%
5 YR SPS GROWTH16.13%
5 YR BPS GROWTH15.88%

TICKRZ RANK
Davita Inc receives an A ranking in our proprietary multi-factor ranking approach that blends valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Davita Inc's valuation score is comprised of a P/E ratio of 8.9x, a P/B ratio of 2.3x, a P/S ratio of 0.8x, and an EV/EBITDA ratio of 6.3x. Davita Inc ranks 20 out of the S&P 500 constituents on valuation--a relatively strong score.

WARREN BUFFETT RANKING
Davita Inc ranks 27 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Davita Inc warrants further investigation.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is weak. Its position within the Healthcare sector appears to be weak. Either the dynamics of its sector place it in a difficult position or management's executition is to blame for its disappointing performance.

FINANCIAL STRENGTH
Davita Inc has a Piotroski F Score of 7 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 4.11x, a debt/equity ratio of 145% and a Moat Rank of 291 translate to a weak Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors.The company has seen its stock fall by -11.07% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 421. Based on its 12 month stock performance, Davita Inc will not appeal to momentum investors.

VALUE + YIELD
Davita Inc currently does not pay a dividend so it ranks last among S&P 500 companies using our dividend ranking methodology. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 11.4% 5 year annualized EPS growth, 16.1% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 15.9% speak to its impressive growth ranking.